Nomura Asset Management CO LTD Neurocrine Biosciences Inc Transaction History
Nomura Asset Management CO LTD
- $32.3 Billion
- Q4 2024
A detailed history of Nomura Asset Management CO LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 53,626 shares of NBIX stock, worth $6.37 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
53,626
Previous 56,275
4.71%
Holding current value
$6.37 Million
Previous $6.48 Million
12.98%
% of portfolio
0.02%
Previous 0.02%
Shares
28 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
96.6MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.68 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.2 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$581 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$358 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$301 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.4B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...